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T 
he  migration  of T  cells  is  a  highly regulated  process, 
serving to  distribute  functional  subsets  of cells  to  the 
appropriate tissue or microenvironment. The role of adhe- 
sion  molecules  in  this  process  is  well  appreciated  (1,  2) 
however an additional class of molecules, the chemoattrac- 
tant  cytokines  (chemokines)  and  their  receptors,  are  now 
receiving  considerable  attention,  because  of their  funda- 
mental role not only in leukocyte migration, but also in he- 
matopoiesis, T  cell activation, and leukocyte degranulation 
(3).  In addition,  a recent flurry of papers has demonstrated 
that chemokine receptors act as cofactors for HIV-1  entry 
into cells  (reviewed in references 4,  5).  Two papers in the 
current issue of this journal add significantly to our under- 
standing of the role of chemokines and their receptors in T 
cell traffic. 
There  are  two  major  families  of chemokines,  termed 
CXC  and CC according to the presence or absence of an 
amino acid between a pair of cysteine residues near the NH 2 
terminus.  One  of the  first members  of the  chemokines  to 
be identified was IP-10, in  1985  (6),  and now 40 or more 
are  known  to  exist.  The  first  receptors  for  chemokines 
were identified several years ago (7,  8), and were found to 
be seven transmembrane  spanning receptors  (7TMP,.),  that 
signal  through  G  protein  interactions  (3,  9,  10).  7TMR 
also function for the classical chemoattractants, such as fmlp 
and C5a (11), and also for the chemotaxis of primitive spe- 
cies such as Dictyostelium (12). 
The human chemokine receptors that have been defined 
to  date  are  listed  in  Table  1.  The  precise  expression  of 
many of these receptors is not yet known, because specific 
mAbs are not available. For T  cells,  PCI:k or northern blot- 
ting indicates  that  the  five known  receptors  for CC  che- 
mokines,  defined  as  CCR1  to CCR5  (A new nomencla- 
ture for CC and CXC chemokine receptors was adopted at 
the  1996 Gordon Research conference on chemotactic cy- 
tokines.  See Table  1.),  are expressed  on subsets  of T  cells. 
Delineating  exactly  which  subsets  is  an  area  of intense 
study, because chemokine receptor expression may explain 
the  localization  or migration  of various  cell types, such as 
TH1  or TH2 T  cells,  or tissue homing subsets.  It may also 
determine  which T  cells  are infected with different strains 
of HIV-1. A surprising finding is that, within the T  lineage, 
many of the known chemokine receptors are restricted  to 
activated  or  memory  (CD45RO +)  type  cells.  The  exact 
nature  of CD45RO + T  cells  is still  unclear  (13),  however 
they  do  show  major  differences  from CD45RA +  T  ceils 
with respect to adhesion properties in vitro, and migration 
patterns in vivo (13,  14). The MCP-1  receptor (CCP,.2)  is 
expressed on the CD26  hi CD45RO + T  cell subset, and it is 
these  T  cells  that respond to MCP-1  in chemotaxis assays 
(15,  16).  Likewise,  T  cells  responding  to  P,.ANTES  in 
chemotaxis assays are of the memory phenotype (17), sug- 
gesting  that  the  RANTES  receptors  (CCR.1,  CCR4,  or 
CCR5) are restricted to this type ofT cell. Some of the or- 
phan receptors  show  a similar pattern.  BLP,-1,  which  has 
similarity  to  the  CXC  receptor  family,  is  expressed  on  a 
subset ofCD45RO + T  cells,  as well as on B  cells  (18). The 
two IL-8 receptors, CXCP,1 and CXCP,2, are restricted to 
NK-like cells  within the T  lineage  (16).  However most of 
the chemokine receptors are expressed by several leukocyte 
types, and can also be expressed  on epithelial  cells  or neu- 
ronal cells. 
A  New CXC Receptor Restricted  to Activated T  Cells 
In this issue,  Loetscher et al.  (19)  describe  a third CXC 
chemokine  receptor,  designated  CXCP,3  (Table  1). 
CXCR.3  is a  7TMP,. that signals in response  to the  CXC 
chemokines  IP-10  and  Mig.  Several  features  of CXCR3 
and its  ligands  IP-10 and Mig are particularly noteworthy. 
First,  CXCR3  is highly restricted  to activated T  cells  and 
NK  cells,  and  not  other  leukocytes,  unlike  most  of the 
other  receptors  (Table  1).  Thus  IP-10 or Mig signaling is 
potentially  an  important  mechanism for selective  homing 
of activated/effector cells,  which preferentially  accumulate 
in some inflammatory sites  (20), as well as in many tumors. 
There  is a clear rationale  to focus effector T  cells  to these 
sites,  since  this  is where  an effector arm of the  T  cell im- 
mune system is needed. Once T  cells gain entry to a tissue, 
IP-10/Mig-CXCR.3  interaction  may also be important  to 
position effector T  cells,  for instance close to the inflamma- 
tory stimulus,  or within a tumor. 
A distinguishing feature of IP-10 and Mig is that they are 
both highly inducible by ",/interferon or LPS. Indeed IP-10 
was one of the first chemokines to be identified, through its 
induction  in  various  cells  by  y  interferon  (6).  Until  re- 
cently, the significance of IP-10 has been unclear, since no 
clear  function  could  be  ascribed  to  it.  IP-10  was  found, 
somewhat  contentiously,  to specifically attract  activated  T 
cells  (21), and this has now been confirmed by Loetscher et 
al.  (19).  Mig, which is a close relative of IP-10, was found 
to act selectively on tumor infiltrating T  ceils and activated 
T  cells  (22).  Little  is known about the  expression  of Mig, 
but  IP-10 is  expressed  abundantly in certain inflammatory 
lesions,  particularly  those  characterized  by T  cell  infiltra- 
tion, such as delayed type hypersensitivity responses in skin 
(23), and in EAE (24). 
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Volume 184  September  1996  799-802 Table  1.  Chemokine  Receptors, Their Lt~oancls, and Their Predominant Expression Pattern on Leukocytes 
Chemokine receptor  Old names  Ligands defined to date  Predominant expression 
CCR1  CC CKR1  MIP-I~, tKANTES, MCP-3  Mono, T, 
CCR2a,b  MCP-11Ka,b  MCP-1, MCP-3, MCP-4  Mono, T, baso. 
CCIK3  CKIK-3  eotaxin,  1KANTES, MCP-2,3,4  Eos, baso. 
CCR4  RANTES, MIP-I~, MCP-1  Baso., T 
CC1K5  CC CKR5  RANTES, MIP-10< MIP-113  Mono, T, 
CXCR1  IL-8 RA, IL-8 IK1  IL-8  Neutrophils, NK 
CXC1K2  IL-8 RB, IL-8 R2  IL-8, GiKOo~, NAP-2, ENA-78  Neutrophils, NK 
CXCR3  None  IP-10, Mig  Act. T 
CXCR4  Fusin/humstr/Lestr  SDF-1  Widely expressed 
No designation  BLR-I  ?  B, memory T 
"  BLR-2/EBI1  ~  B, act. T 
"  V28  ; 
cos, eosinophils; baso., basophils; mon0, monocytes; act. T, activated T cells; B, B cells. 
SDF-I,  an  Unusual  CXC-like  Chemokine 
IP-10/Mig  interaction  with  CXCR3  clearly establishes 
that CXC chemokines are important for the migration of T 
cells,  and not just granulocytes. A  second report in this is- 
sue  (25)  shows  that  a  CXC-like  chemokine,  stromal  cell- 
derived factor 1 (SDF-1) is actually one of the most effica- 
cious chemokines for T  and B  cell migration i.e., it attracts 
a high percentage of these cells.  SDF-1 was originally noted 
for its  effects  on B  cell proliferation  (26)  but it  clearly has 
functions on other cell types, even outside the immune sys- 
tem.  Technically  SDF-1  belongs  to  the  CXC  family,  al- 
though it shows equidistant sequence homology to CC and 
CXC  chemokines,  and  is  highly  conserved  in  evolution 
suggesting  that  it  may  be  a  primordial  chemokine.  The 
constitutive expression of SDF-1  in a broad range of tissues 
(26)  prompted Bleul et al. (25) to speculate that SDF-1 may 
be relevant for basal trafficking of cells,  rather than for in- 
flammation.  The efficacious attraction oft  cells  by SDF-1 
indicates  that  the  receptor  for  this  chemokine,  might  be 
nmch  more  widely  expressed  than  most  of  the  other 
chemokine  receptors  such  as  CCR1  through  CCR5,  or 
CXCIK3. The receptor for SDF-1  has just been identified 
as LEST1K/fusin  (26a,  26b),  a little  studied,  7TM1K which 
gained notoriety recently because of its role as a coreceptor 
for HIV infection (26c).  SDF-1  is a potent inhibitor of in- 
fection  by  lymphocyte-tropic  HIV-1  strains.  The  reason 
why  LEST1K/fusin  (now  termed  CXCtL4,  Table  1)  and 
CCR5  are  so  important  for  HIV  entry  is  uncertain,  al- 
though it may relate to their levels of expression on T  cells 
and monocytes. SDF-1  and its  receptor might be involved 
in lymph node homing by lymphocytes. Lymphocyte mi- 
gration  across  high  endothelial  venules  is  pertussis  toxin 
sensitive  (27),  indicating  the  involvement  of a  G  protein 
coupled 7TMIK. 
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Chemokine Receptor Expression  on  T  Cells Is 
Tightly Regulated 
Apart from the SDF-1  receptor, most of the chemokine 
receptors  are  upregulated  on activated/memory  subsets  of 
T  cells.  This  appears  to  relate  to  the  effects  of IL-2.  IL-2 
was found to upregulate markedly the expression of CCIK1 
and CCR2 on CD451KO + T  cells  when activated in vitro, 
and  this  correlated with  the  ability  of these  T  cells  to re- 
spond to RANTES and MCP-1  in chemotaxis assays  (28). 
This induction of responsiveness was not related simply to 
activation, since exogenous IL-2 was obligatory. This effect 
of IL-2 could be partially nfimicked by IL-4, IL-10, or IL-12. 
The  IL-2  effect  may  explain  the  restricted  expression  of 
many of the chemokine receptors,  since activation  and in- 
duction of high affinity IL-2 receptors may be a prerequi- 
site  for receptor upregulation.  This  has implications for at 
least two fields  of human health.  HIV uses  chemokine re- 
ceptors as cofactors for cell entry, which suggests that acti- 
vated,  IL-2-stimulated T  cells,  which are abundant  during 
normal immune  responses,  would be the cells  targeted  for 
infection by the  virus.  Memory  CD4 +  T  cells,  which  are 
the  descendants  of activated  T  cells,  are  selectively lost  in 
HIV-l-infected  individuals  (29).  Another  important  coi~- 
sideration  is that  IL-2 therapy is  used for the  treatment  of 
various  tumors  in  humans.  IL-2  treatment  in  humans  or 
mice leads, in many cases,  to a multiple  organ lymphocytic 
infiltration  (30),  which probably relates  to  chemokine  re- 
ceptor induction. 
Chemokines  steer  cells  in  the  right  direction,  however 
adhesion molecules play a critical role in the selective adhe- 
sion ofT  cell subsets to inflamed endothelium,  or4, [31, [37 
or ~32 integrins, or P- and E-selectin ligands, mediate adhe- 
sion of blood-borne cells to inflamed endothelium, particu- 
larly subsets of memory and activated T  cells which express the highest levels of these molecules  (20).  Since the devel- 
opment of the multi-step paradigm of leukocyte binding to 
blood vessel endothelium (1, 2, 31), chemokines have been 
proposed as one of the signaling elements for integrin acti- 
vation,  which  could  act  combinatorially  with  adhesion 
molecules  to  determine  leukocyte  traffic  to  tissues  (31). 
This  might be especially important for relatively restricted 
receptors, such as the IL-8 receptors on neutrophils (3) and 
the  eotaxin  receptor  (CCR3)  on  eosinophils  (32).  Che- 
mokines,  as well as classical  chemoattractants,  can certainly 
signal  integrin  mediated  adhesion  of cells  to  ICAM-1  or 
VCAM-1  (33,  34).  Recent studies  suggest that firm adhe- 
sion triggering via chemokine receptors appears to require 
high numbers of receptors on the cell surface (34), which is 
the  case for the  IL-8 receptors  on neutrophils,  or the  eo- 
taxin receptor on eosinophils  (~60,000  receptors per cell). 
Chemokine receptor levels on T  cells usually number only 
1,000-4,000,  at least for the receptors characterized so far, 
which may explain why chemokines acting on T  cells  ap- 
pear  more  important  for  transendothelial  migration  or 
chemotaxis within  a  tissue,  rather  than integrin  activation 
on blood vessel endothelium (34, 35). 
Whatever  their point  of action  is,  blocking chemokine 
function  has  profound  effects  on inflammatory  responses. 
MIP-lot-deficient  mice  have  impaired  immune  responses 
to certain  viral  infections  (36),  and  anti-MIP-lcx  adminis- 
tered to mice markedly affects the recruitment  of immune 
cells  to a variety of inflammatory sites  (37).  Similarly, anti- 
IL-8 in various animal models of ischemic reperfusion in- 
jury  inhibits  neutrophil  recruitment  and  decreases  tissue 
damage (37), and anti-MCP-1  in rats inhibits DTH-medi- 
ated  inflammation  (38).  The  chemokines  are  important 
components  of  the  immune  response,  and  the  recent 
knowledge  of their  actions  provides  a  basis  for designing 
new therapies for a variety of human diseases. 
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